Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

A significant proportion of estrogen receptor‐positive (ER+) breast cancer (BC) initially responds to endocrine therapy but eventually evolves into therapy‐resistant BC. Transcription factor AP‐2 gamma (TFAP2C) is a known regulator of ER activity, and high expression of TFAP2C is associated with a d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junhao, Liu, Zexuan, Li, Mengxing, Tang, Weiwei, Pratap, Uday P., Luo, Yiliao, Altwegg, Kristin A., Li, Xiaonan, Zou, Yi, Zhu, Hong, Sareddy, Gangadhara R., Viswanadhapalli, Suryavathi, Vadlamudi, Ratna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024722/
https://www.ncbi.nlm.nih.gov/pubmed/33269540
http://dx.doi.org/10.1002/1878-0261.12871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024722/
https://www.ncbi.nlm.nih.gov/pubmed/33269540
http://dx.doi.org/10.1002/1878-0261.12871

Ejemplares similares